Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma-Reference-Cited by-同舟云学术

Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma

Published:2015-10 Issue:1 Volume:117 Page:183-187
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Ponsky Lee,Lo Simon S.,Zhang Yuxia,Schluchter Mark,Liu Yiying,Patel Ravi,Abouassaly Robert,Welford Scott,Gulani Vikas,Haaga John Robert,Machtay Mitchell,Ellis Rodney J.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference22 articles.

1. Rising incidence of renal cell cancer in the United States;Chow;JAMA,1999

2. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature;Chawla;J Urol,2006

3. Guideline for management of the clinical T1 renal mass;Campbell;J Urol,2009

4. Enhancing renal masses with zero net growth during active surveillance;Kunkle;J Urol,2007

5. Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar;Siu;Urol Oncol,2007

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers;Frontiers in Oncology;2024-08-13

2. Stereotactic body radiation therapy for primary renal cell carcinoma: A review on behalf of the CC-AFU;The French Journal of Urology;2024-07

3. Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Case-Based Radiosurgery Society Practice Guide;Practical Radiation Oncology;2024-07

4. Dose-response of localized renal cell carcinoma after stereotactic body radiation therapy: A meta-analysis;Radiotherapy and Oncology;2024-05

5. Stereotactic body radiotherapy for inoperable patients with renal carcinoma;The French Journal of Urology;2024-03